P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
Nuria Martinez-Cibrian,
Sergi Betriu,
Valentín Ortiz-Maldonado,
Daniel Esteban,
Natalia Tovar,
Ana Triguero Moreno,
Leticia Alserawan,
Mercedes Montoro,
Anna Van Muyden,
Maike Spoon,
Margot Pont,
Christian Jacques,
Julio Delgado
Affiliations
Nuria Martinez-Cibrian
1 Hospital Clínic de Barcelona, Barcelona, Spain
Sergi Betriu
1 Hospital Clínic de Barcelona, Barcelona, Spain
Valentín Ortiz-Maldonado
1 Hospital Clínic de Barcelona, Barcelona, Spain
Daniel Esteban
1 Hospital Clínic de Barcelona, Barcelona, Spain
Natalia Tovar
1 Hospital Clínic de Barcelona, Barcelona, Spain
Ana Triguero Moreno
1 Hospital Clínic de Barcelona, Barcelona, Spain
Leticia Alserawan
1 Hospital Clínic de Barcelona, Barcelona, Spain
Mercedes Montoro
1 Hospital Clínic de Barcelona, Barcelona, Spain
Anna Van Muyden
2 CellPoint BV, a Galapagos company, Leiden, The Netherlands
Maike Spoon
2 CellPoint BV, a Galapagos company, Leiden, The Netherlands
Margot Pont
2 CellPoint BV, a Galapagos company, Leiden, The Netherlands
Christian Jacques
2 CellPoint BV, a Galapagos company, Leiden, The Netherlands
